FDA approves Telix brain cancer imaging drug Pixclara
The Food and Drug Administration approved Telix Pharmaceuticals’ NASDAQ:TLX Pixclara, a radioactive imaging drug used to help evaluate patients with glioma, the company said Sunday.Pixclara, also known as floretyrosine F 18, is approved for use with positron emission tomography to help distinguish…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.